Across TCGA cell cohorts, BRICD5 mutation is significantly associated with the RNA expression of many other genes, with 24 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible BRICD5-associated genes across cancer lineages are AQP12A, ASZ1, and TMEM61. Each is linked with BRICD5 in more than 1 cancer types. Because this analysis shows association rather than direction, both BRICD5-to-partner and partner-to-BRICD5 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (BRICD5→partner) and Y-score (partner→BRICD5) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Myeloma	AQP12A →	+0.076	+4.807	<.001	.006	3	2
BLOOD_Leukemia	ASZ1 →	+0.116	+4.567	<.001	.001	3	2
BLOOD_Myeloma	TMEM61 →	+1.126	+4.807	.001	.006	3	1
BLOOD_Myeloma	SPATA3 →	+0.080	+4.807	<.001	.006	3	1
BLOOD_Myeloma	ADGRA1 →	+0.006	+4.807	<.001	.006	3	1
BLOOD_Myeloma	GALP →	+0.046	+4.807	<.001	.006	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 24 associations by consensus.

Exploration

BRICD5 survival (RNA) · tumor vs normal (RNA) · all BRICD5 data types